4
Changes in Ownership
Immunocore Holdings plc Filed Acc 0001415889-24-005720
HEAD OF R&D sold 83,491 shares at an average $70.79 ($5,910,318)
- HEAD OF R&D acquired 83,491 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Berman David M HEAD OF R&D | 2024-02-26 | Option exercise 10b5-1 | +28,553 | $17.46 | $498,535 | 28,553 | D |
| Berman David M HEAD OF R&D | 2024-02-26 | Sale 10b5-1 | −26,516 | $70.60 | $1,872,030 | 2,037 | D |
| Berman David M HEAD OF R&D | 2024-02-26 | Sale 10b5-1 | −2,037 | $71.31 | $145,258 | 0 | D |
| Berman David M HEAD OF R&D | 2024-02-27 | Option exercise 10b5-1 | +54,938 | $17.46 | $959,217 | 54,938 | D |
| Berman David M HEAD OF R&D | 2024-02-27 | Sale 10b5-1 | −4,448 | $69.45 | $308,914 | 50,490 | D |
| Berman David M HEAD OF R&D | 2024-02-27 | Sale 10b5-1 | −21,152 | $70.42 | $1,489,524 | 29,338 | D |
| Berman David M HEAD OF R&D | 2024-02-27 | Sale 10b5-1 | −25,944 | $71.32 | $1,850,326 | 3,394 | D |
| Berman David M HEAD OF R&D | 2024-02-27 | Sale 10b5-1 | −3,394 | $71.97 | $244,266 | 0 | D |
| Derivatives | |||||||
| Berman David M HEAD OF R&D | 2024-02-26 | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −28,553 | 363,237 | D | ||
| Berman David M HEAD OF R&D | 2024-02-27 | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −54,938 | 308,299 | D | ||
| Open-market sales · 83,491 sh · avg $70.79 · $5,910,318 | |||||||
Loading xslF345X05/form4-02282024_040201.xml…